IGFBP7 and acute kidney injury: TIMP-2/ IGFBP7 shows the best accuracy among AKI biomarkers in patients with various types of AKI condition including AKI after kidney transplantation and AKI in critical care settings, sepsis and platinum-based chemotherapy, and chronic kidney damage induced by diabetes mellitus and congestive heart failure [112,113].